These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 28686625)

  • 41. Temperature Sensitive Mutations in Influenza A Viral Ribonucleoprotein Complex Responsible for the Attenuation of the Live Attenuated Influenza Vaccine.
    Martínez-Sobrido L; Peersen O; Nogales A
    Viruses; 2018 Oct; 10(10):. PubMed ID: 30326610
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Acceptability of live attenuated influenza vaccine by vaccine providers in Quebec, Canada.
    Dubé E; Gagnon D; Kiely M; Boulianne N; Landry M
    Hum Vaccin Immunother; 2015; 11(4):956-60. PubMed ID: 25751608
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Safety of Russian-backbone seasonal trivalent, live-attenuated influenza vaccine in a phase II randomized placebo-controlled clinical trial among children in urban Bangladesh.
    Ortiz JR; Goswami D; Lewis KD; Sharmeen AT; Ahmed M; Rahman M; Rahman MZ; Feser J; Neuzil KM; Brooks WA
    Vaccine; 2015 Jun; 33(29):3415-21. PubMed ID: 25917680
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Shedding of Ann Arbor strain live attenuated influenza vaccine virus in children 6-59 months of age.
    Mallory RM; Yi T; Ambrose CS
    Vaccine; 2011 Jun; 29(26):4322-7. PubMed ID: 21513761
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sequential Immunization With Live-Attenuated Chimeric Hemagglutinin-Based Vaccines Confers Heterosubtypic Immunity Against Influenza A Viruses in a Preclinical Ferret Model.
    Liu WC; Nachbagauer R; Stadlbauer D; Solórzano A; Berlanda-Scorza F; García-Sastre A; Palese P; Krammer F; Albrecht RA
    Front Immunol; 2019; 10():756. PubMed ID: 31105689
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Optimizing the Live Attenuated Influenza A Vaccine Backbone for High-Risk Patient Groups.
    Bonifacio JPPL; Williams N; Garnier L; Hugues S; Schmolke M; Mazel-Sanchez B
    J Virol; 2022 Oct; 96(20):e0087122. PubMed ID: 36190240
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparing influenza vaccine efficacy against mismatched and matched strains: a systematic review and meta-analysis.
    Tricco AC; Chit A; Soobiah C; Hallett D; Meier G; Chen MH; Tashkandi M; Bauch CT; Loeb M
    BMC Med; 2013 Jun; 11():153. PubMed ID: 23800265
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nasal shedding of vaccine viruses after immunization with a Russian-backbone live attenuated influenza vaccine in India.
    Dar L; Krishnan A; Kumar R; Dhakad S; Choudekar A; Bagga S; Sharma A; Kumar A; Jethani J; Saha S; Amarchand R; Kumar R; Choudhary A; Narayan VV; Gopal G; Lafond KE; Lindstrom S
    Influenza Other Respir Viruses; 2023 Jun; 17(6):e13149. PubMed ID: 37380175
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Flu myths: dispelling the myths associated with live attenuated influenza vaccine.
    Tosh PK; Boyce TG; Poland GA
    Mayo Clin Proc; 2008 Jan; 83(1):77-84. PubMed ID: 18174020
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Live attenuated influenza vaccine--a review.
    Gasparini R; Amicizia D; Lai PL; Panatto D
    J Prev Med Hyg; 2011 Sep; 52(3):95-101. PubMed ID: 22010534
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The use of live attenuated influenza vaccine (LAIV) in healthcare personnel (HCP): guidance from the Society for Healthcare Epidemiology of America (SHEA).
    Talbot TR; Babcock H; Cotton D; Maragakis LL; Poland GA; Septimus EJ; Tapper ML; Weber DJ
    Infect Control Hosp Epidemiol; 2012 Oct; 33(10):981-3. PubMed ID: 22961016
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunization of institutionalized asthmatic children and patients with psychomotor retardation using live attenuated cold-adapted reassortment influenza A H1N1, H3N2 and B vaccines.
    Miyazaki C; Nakayama M; Tanaka Y; Kusuhara K; Okada K; Tokugawa K; Ueda K; Shibata R; Nishima S; Yamane N
    Vaccine; 1993; 11(8):853-8. PubMed ID: 8356846
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association of Prior Vaccination With Influenza Vaccine Effectiveness in Children Receiving Live Attenuated or Inactivated Vaccine.
    McLean HQ; Caspard H; Griffin MR; Gaglani M; Peters TR; Poehling KA; Ambrose CS; Belongia EA
    JAMA Netw Open; 2018 Oct; 1(6):e183742. PubMed ID: 30646262
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunogenicity and Cross Protection in Mice Afforded by Pandemic H1N1 Live Attenuated Influenza Vaccine Containing Wild-Type Nucleoprotein.
    Rekstin A; Isakova-Sivak I; Petukhova G; Korenkov D; Losev I; Smolonogina T; Tretiak T; Donina S; Shcherbik S; Bousse T; Rudenko L
    Biomed Res Int; 2017; 2017():9359276. PubMed ID: 28210631
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Influenza Among Young Children in Bangladesh: Clinical Characteristics and Outcomes From a Randomized Clinical Trial.
    Rotrosen E; Zaman K; Feser J; Ortiz JR; Goswami D; Sharmeen AT; Rahman M; Lewis KDC; Rahman MZ; Barin B; Brooks WA; Neuzil KM
    Clin Infect Dis; 2017 Nov; 65(11):1914-1920. PubMed ID: 29028980
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Alternative Strategy for a Quadrivalent Live Attenuated Influenza Virus Vaccine.
    Wan Z; Cardenas Garcia S; Liu J; Santos J; Carnaccini S; Geiger G; Ferreri L; Rajao D; Perez DR
    J Virol; 2018 Nov; 92(21):. PubMed ID: 30135124
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Safety and immunogenicity of a live attenuated influenza H5 candidate vaccine strain A/17/turkey/Turkey/05/133 H5N2 and its priming effects for potential pre-pandemic use: a randomised, double-blind, placebo-controlled trial.
    Pitisuttithum P; Boonnak K; Chamnanchanunt S; Puthavathana P; Luvira V; Lerdsamran H; Kaewkungwal J; Lawpoolsri S; Thanachartwet V; Silachamroon U; Masamae W; Schuetz A; Wirachwong P; Thirapakpoomanunt S; Rudenko L; Sparrow E; Friede M; Kieny MP
    Lancet Infect Dis; 2017 Aug; 17(8):833-842. PubMed ID: 28533093
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Effect of Preexisting Immunity on Virus Detection and Immune Responses in a Phase II, Randomized Trial of a Russian-Backbone, Live, Attenuated Influenza Vaccine in Bangladeshi Children.
    Brickley EB; Wright PF; Khalenkov A; Neuzil KM; Ortiz JR; Rudenko L; Levine MZ; Katz JM; Brooks WA
    Clin Infect Dis; 2019 Aug; 69(5):786-794. PubMed ID: 30481269
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Adenoviral Vectors as Vaccines for Emerging Avian Influenza Viruses.
    Kerstetter LJ; Buckley S; Bliss CM; Coughlan L
    Front Immunol; 2020; 11():607333. PubMed ID: 33633727
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An open-label phase I trial of a live attenuated H2N2 influenza virus vaccine in healthy adults.
    Talaat KR; Karron RA; Liang PH; McMahon BA; Luke CJ; Thumar B; Chen GL; Min JY; Lamirande EW; Jin H; Coelingh KL; Kemble GW; Subbarao K
    Influenza Other Respir Viruses; 2013 Jan; 7(1):66-73. PubMed ID: 22417012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.